297 related articles for article (PubMed ID: 24029605)
41. [Angiogenesis and the regulation of antitumor defense].
Pappas NP; Hillen HF; Wagstaff J; Griffioen AW
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1555-9. PubMed ID: 10443280
[TBL] [Abstract][Full Text] [Related]
42. The role of interleukin-6 in gynaecological malignancies.
Coward JI; Kulbe H
Cytokine Growth Factor Rev; 2012 Dec; 23(6):333-42. PubMed ID: 23031497
[TBL] [Abstract][Full Text] [Related]
43. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
45. The possible role of chemotherapy in antiangiogenic drug resistance.
Bocci G; Loupakis F
Med Hypotheses; 2012 May; 78(5):646-8. PubMed ID: 22365648
[TBL] [Abstract][Full Text] [Related]
46. New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.
Taylor M; Rössler J; Geoerger B; Vassal G; Farace F
Expert Opin Investig Drugs; 2010 Jul; 19(7):859-74. PubMed ID: 20470190
[TBL] [Abstract][Full Text] [Related]
47. Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy.
Hawinkels LJ; Garcia de Vinuesa A; Ten Dijke P
Expert Opin Investig Drugs; 2013 Nov; 22(11):1371-83. PubMed ID: 24053899
[TBL] [Abstract][Full Text] [Related]
48. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
49. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
[TBL] [Abstract][Full Text] [Related]
50. Do anti-angiogenic cancer therapies increase risk of significant weight loss?
Zhang S; Yu M; Wei Y
Expert Opin Drug Saf; 2014 Apr; 13(4):473-82. PubMed ID: 24588304
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
[TBL] [Abstract][Full Text] [Related]
52. Anti-angiogenic therapy, a new player in the field of sarcoma treatment.
Versleijen-Jonkers YM; Vlenterie M; van de Luijtgaarden AC; van der Graaf WT
Crit Rev Oncol Hematol; 2014 Aug; 91(2):172-85. PubMed ID: 24613529
[TBL] [Abstract][Full Text] [Related]
53. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.
McIntyre A; Harris AL
EMBO Mol Med; 2015 Apr; 7(4):368-79. PubMed ID: 25700172
[TBL] [Abstract][Full Text] [Related]
54. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
Yamamizu K; Hamada Y; Narita M
Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
[TBL] [Abstract][Full Text] [Related]
55. The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials.
Rüegg C; Meuwly JY; Driscoll R; Werffeli P; Zaman K; Stupp R
Curr Mol Med; 2003 Dec; 3(8):673-91. PubMed ID: 14682490
[TBL] [Abstract][Full Text] [Related]
56. Angiogenic and anti-angiogenic factors in adrenal tumours.
Jurczyńska J; Zieleniewski W; Stepień H; Komorowski J
Endokrynol Pol; 2006; 57(6):633-40. PubMed ID: 17253437
[TBL] [Abstract][Full Text] [Related]
57. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
Carmeliet P; Jain RK
Nat Rev Drug Discov; 2011 Jun; 10(6):417-27. PubMed ID: 21629292
[TBL] [Abstract][Full Text] [Related]
58. Latest Results for Anti-Angiogenic Drugs in Cancer Treatment.
Frandsen S; Kopp S; Wehland M; Pietsch J; Infanger M; Grimm D
Curr Pharm Des; 2016; 22(39):5927-5942. PubMed ID: 27426129
[TBL] [Abstract][Full Text] [Related]
59. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
60. Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.
Murphy AG; Casey R; Maguire A; Tosetto M; Butler CT; Conroy E; Reynolds AL; Sheahan K; O'Donoghue D; Gallagher WM; Fennelly D; Kennedy BN; O'Sullivan J
Sci Rep; 2016 Oct; 6():34523. PubMed ID: 27739445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
